NanoEnTek Inc
KOSDAQ:039860
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
NanoEnTek Inc
Accounts Receivables
NanoEnTek Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NanoEnTek Inc
KOSDAQ:039860
|
Accounts Receivables
₩8.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-2%
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Accounts Receivables
₩1.2T
|
CAGR 3-Years
12%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Accounts Receivables
₩3.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Accounts Receivables
₩3.6B
|
CAGR 3-Years
95%
|
CAGR 5-Years
53%
|
CAGR 10-Years
26%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Accounts Receivables
₩99.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Accounts Receivables
₩24.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
3%
|
CAGR 10-Years
10%
|
|
NanoEnTek Inc
Glance View
NanoenTek, Inc. engages in the manufacture and sale of diagnostics and analytical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-08-16. is a Korea-based company mainly engaged in the manufacturing of point of care testing (POCT) medical equipment and biotechnology research equipment. The Company’s products consist of Countess, EVE and ADAM, which are cell counting systems; NEON, which are gene delivery systems; JuLI, which are fluorescence microscopes, and chips, which are consumables of cell counting systems. The company also provides diagnostic medical equipment, such as FREND systems, which are quantitative immunoassay analyzing devices; ADAM-rWBC, an analytical device for counting the number of residual white blood cells (rWBCs) in leukoreduced blood products, and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is NanoEnTek Inc's Accounts Receivables?
Accounts Receivables
8.3B
KRW
Based on the financial report for Sep 30, 2025, NanoEnTek Inc's Accounts Receivables amounts to 8.3B KRW.
What is NanoEnTek Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-2%
Over the last year, the Accounts Receivables growth was 5%. The average annual Accounts Receivables growth rates for NanoEnTek Inc have been -2% over the past three years , 7% over the past five years , and -2% over the past ten years .
